Table of Contents
CHAPTER 1: EXECUTIVE SUMMARY
INDUSTRY OVERVIEW
SCOPE AND METHODOLOGY
BRAZIL IVD MARKET SUMMARY
Figure 1-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other)
CHAPTER 2: BRAZIL OVERVIEW
POPULATION
Table 2-1: Total Midyear Population by Broad Age Group: Brazil (million persons), 2010-2050 (0-14, 15-64, 65+)
Figure 2-1: Total Midyear Population by Broad Age Group: Brazil (million persons), 2010-2050 (0-14, 15-64, 65+)
Figure 2-2: Total Number of Births in Brazil by Year, 1970-2010, and Forecast 2020-2050
Figure 2-3: Brazil Life Expectancy at Birth in Years, 2010-2050
Population Urbanization
ECONOMY AND HEALTH SPENDING
Figure 2-4: Brazil GDP, GDP (PPP) and Health Spending, 1990-2015
Figure 2-5: Brazil Distribution of Income or Consumption by Quintile, 1990-2014
CHAPTER 3: THE HEALTH SYSTEM IN BRAZIL
HEALTH INFRASTRUCTURE
Figure 3-1: Brazilian Coverage Rate (%) for Private Health Plans and Public Health Plans, 2003-2015 (Private Medical Aid Plan Beneficiaries with or without Dental Care, Public Health Plan Beneficiaries)
Figure 3-2: Health Expenditures, Public vs. Private as a % of Total Health Expenditures, 2015 (Private, Public)
Medical Facilities
Figure 3-3: Distribution of JCI Accredited Facilities by Metropolitan Area (%) (Sao Paulo, Rio de Janeiro, Recife, Brasilia, Porto Alegre, Others)
Figure 3-4: Distribution of JCI Accredited Facilities by Type (%) (Hospital Program, Academic Medical Center, Ambulatory Care, Home Care, Medical Transport, Primary Care)
Figure 3-5: Hospital Bed Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
Physicians and Health Professionals
Figure 3-6: Physician Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
Figure 3-7: Nurse/Midwife Density per 1,000 Population by Country, 2016 Estimates (US, UK, Singapore, Japan, Germany, China, Canada, Brazil, Australia)
The Brazilian Diagnostic Laboratory Environment
Figure 3-8: Laboratories and Collection Sites in Brazil by Type (%), 2016 (Collection Sites, all types; Commercial Laboratories; Hospital-based Laboratories)
Figure 3-9: Distribution of Volume, Brazil’s Leading Clinical Laboratory Service Providers (%), 2016
Medical Device Regulation
Table 3-1: Market Divers and Inhibitors for Entering Brazil’s Medical Device Market
Figure 3-10: Market Entry Complexity for Foreign Operators in Brazil
Brazil’s Growing Medical Tourism Industry
HEALTH INDICATORS
General Health
Disease Profiles in Brazil
Table 3-2: Top 5 Cancers Affecting Brazilian Population (ranked by total number of cases), 2010-2016 (Male, Female, Total [both sexes])
Figure 3-11: Highly Prevalent Medical Conditions/Diseases in Brazil (Zika virus, Tuberculosis, Malaria, Leprosy, HIV, Diabetes, Dengue, Chagas disease, Cardiovascular diseases, Cancer)
Surgical Procedures in Brazil
Table 3-3: Surgical Procedures in Brazil as Compared to Rest of Latin America (%) (Cardiovascular procedures, Digestive/Gastrointestinal procedures, Obstetrical/Gynecological procedures, Orthopedic procedures, ENT/Respiratory procedures, Urinary surgical procedures, Cosmetic/Aesthetic procedures, Other procedures, Total)
Figure 3-12: Brazil, Mexico and Rest of LATAM Distribution of Population Compared to Surgical Procedures (%)
CHAPTER 4: IVD MARKETS IN BRAZIL
BRAZIL IVD MARKET SUMMARY
Table 4-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total)
Figure 4-1: Brazil In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology, POC, Histology, Other)
Figure 4-2: Brazil In Vitro Diagnostic Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassays, Microbiology/Molecular, POC, Histology, Other)
CLINICAL CHEMISTRY
Figure 4-3: Brazil – Clinical Chemistry Market, 2016-2021
IMMUNOASSAY
Table 4-2: Brazil – Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
Figure 4-4: Brazil – Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
MICROBIOLOGY/MOLECULAR
Table 4-3: Brazil – Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
Figure 4-5: Brazil Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
POINT-OF-CARE
Table 4-4: Brazil – POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Infectious Disease, POC Other, Total POC)
Figure 4-6: Brazil POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Infectious Disease, Others)
HISTOLOGY
Figure 4-7: Brazil – Histology Market, 2016-2021
CHAPTER 5: COMPETITIVE ANALYSIS AND PROFILES
COMPETITIVE SUMMARY
Table 5-1: Leading IVD Market Suppliers in Brazil, Market Share Percentage, 2016
Figure 5-1: Leading IVD Market Suppliers in Brazil, 2016 (%)
ABBOTT LABORATORIES
Table 5-2: Abbott Laboratories Company Summary
Company Overview
Company Performance
Product Summary
ALERE
Table 5-3: Alere Company Summary
Company Overview
Performance Review
Product Summary
BECTON, DICKINSON AND COMPANY
Table 5-4: Becton, Dickinson and Company Summary
Company Overview
Company Performance
Product Summary
BIOMÉRIEUX SA
Table 5-5: bioMerieux Summary
Company Overview
Company Performance
Product Summary
DANAHER CORPORATION
Table 5-6: Danaher Corporation Summary
Company Overview
Company Performance
Product Summary
ROCHE (F. HOFFMAN-LA ROCHE, LTD.)
Table 5-7: Roche Group Summary
Company Overview
Company Performance
Product Summary
SIEMENS HEALTHINEERS
Table 5-8: Siemens Healthineers Company Summary
Company Overview
Company Performance
Product Summary
SYSMEX CORPORATION
Table 5-9: Sysmex Corporation Summary
Company Overview
Company Performance
Product Summary
APPENDIX: SOURCES OF INFORMATION
